PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30400671-3	2018	Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) omega-3 polyunsaturated fatty acids may compete with AA for CYP450-dependent bioactive lipid mediator formation.	Docosahexaenoic Acids	32-52	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	119-125	
30400671-3	2018	Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) omega-3 polyunsaturated fatty acids may compete with AA for CYP450-dependent bioactive lipid mediator formation.	Docosahexaenoic Acids	54-57	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	119-125	
29080699-3	2018	CYP enzymes, previously identified as arachidonic acid (20:4n-6; AA) epoxygenases, accept eicosapentaenoic acid (20:5n-3; EPA) and docosahexaenoic acid (22:6n-3; DHA), the major fish oil n-3 LC-PUFAs, as efficient alternative substrates.	Docosahexaenoic Acids	131-151	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	0-3	
26975734-3	2016	In addition to arachidonic acid, the CYP epoxygenases also metabolize the Omega-3 polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid and docosahexaenoic acid, to generate bioactive lipid epoxide mediators.	Docosahexaenoic Acids	145-165	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	37-40	
27182450-0	2015	CYP-epoxygenase metabolites of docosahexaenoic acid protect HL-1 cardiac cells against LPS-induced cytotoxicity Through SIRT1.	Docosahexaenoic Acids	31-51	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	0-3	
27182450-5	2015	Emerging evidence indicates that cytochrome P450 (CYP) epoxygenase metabolites of DHA, epoxydocosapentaenoic acids (EDPs), produce more potent biological activity compared to its precursor DHA.	Docosahexaenoic Acids	82-85	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	33-48	
27182450-5	2015	Emerging evidence indicates that cytochrome P450 (CYP) epoxygenase metabolites of DHA, epoxydocosapentaenoic acids (EDPs), produce more potent biological activity compared to its precursor DHA.	Docosahexaenoic Acids	82-85	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	50-53	
27182450-5	2015	Emerging evidence indicates that cytochrome P450 (CYP) epoxygenase metabolites of DHA, epoxydocosapentaenoic acids (EDPs), produce more potent biological activity compared to its precursor DHA.	Docosahexaenoic Acids	189-192	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	33-48	
27182450-5	2015	Emerging evidence indicates that cytochrome P450 (CYP) epoxygenase metabolites of DHA, epoxydocosapentaenoic acids (EDPs), produce more potent biological activity compared to its precursor DHA.	Docosahexaenoic Acids	189-192	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	50-53	
27182450-8	2015	Our results illustrate the CYP epoxygenase metabolite of DHA, 19,20-EDP, confers extensive protection to HL-1 cardiac cells against LPS-induced cytotoxicity via activation of SIRT1.	Docosahexaenoic Acids	57-60	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	27-30	
20869469-2	2011	As discussed in the present review, virtually all of the major AA metabolizing CYP isoforms accept a variety of other polyunsaturated fatty acids (PUFA), including linoleic, eicosapentaenoic (EPA) and docosahexaenoic acids (DHA), as efficient alternative substrates.	Docosahexaenoic Acids	201-222	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	79-82	
20869469-2	2011	As discussed in the present review, virtually all of the major AA metabolizing CYP isoforms accept a variety of other polyunsaturated fatty acids (PUFA), including linoleic, eicosapentaenoic (EPA) and docosahexaenoic acids (DHA), as efficient alternative substrates.	Docosahexaenoic Acids	224-227	cytochrome P450 family 4 subfamily F member 3	Homo sapiens	79-82